Clinical Trials Browser

Phase 1 × INDUSTRY × brexucabtagene autoleucel × Clear all

NCT03624036 2023-11-18

ZUMA-8

Phase 1 Terminated

16 enrolled 17 charts

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell